Colorectal cancer (CRC) develops through an adenoma-carcinoma sequence and detection of precancerous colonic adenomas by colonoscopy, and subsequent endoscopic resection, will prevent disease progression, and can be a curative procedure for intramucosal adenocarcinoma [1 -3].
Background and study aims Published data on blue laser imaging (BLI) for detection and differentiation of colonic polyps are limited compared to narrow band imaging (NBI). This study investigated whether BLI can increase the detection rate of colonic polyps and adenomas when com-pared to white light imaging (WLI), and examined use of NICE (NBI International Colorectal Endoscopic) and JNET (Japan NBI Expert Team) classifications with BLI.
Patients and methods Patients aged 50 years and above referred for colonoscopy were randomized to BLI or WLI on withdrawal. Detected polyps were characterized using NICE and JNET classifications under BLI mode and correlated with histology. Primary outcome was adenoma detection rate. Secondary outcomes were utility of NICE and JNET classifications to predict histology using BLI.
Results A total of 182 patients were randomized to BLI (92) or WLI (90). Comparing BLI with WLI, the polyp detection rate was 59.8 % vs 40.0 %, P = 0.008, and the adenoma detection rate was 46. Conclusion BLI increased adenoma detection rate compared to WLI. NICE and JNET classifications can be applied when using BLI for endoscopic diagnosis of HP and LGD but histological confirmation remains crucial.
Clinical.Trials.gov NCT03421600 TRIAL REGISTRATION: Single-Center, randomized, prospective trial NCT03421600 at clinicaltrials.gov [4] . A randomized controlled study utilizing the second-generation NBI system, which has brighter illumination, reported that NBI improved polyp and adenoma detection rates compared to WLI [5] . Conversely, it has been clearly shown that NBI was useful in predicting polyp histology. The NICE (NBI International Colorectal Endoscopic) classification can be applied without magnification whereas the JNET (Japan NBI Expert Team) classification required optical magnification to predict polyp histology [6, 7] .
Blue laser imaging (BLI) (Lasereo System, Fujifilm Corporation, Tokyo, Japan) is another form of narrow-band imaging (NBI). Instead of using an optical filter for white light to produce narrow bandwidths, the BLI system has a unique feature of illumination using two lasers and a white light phosphor to accomplish visual enhancement of surface vessels and structures. A laser with a wavelength of 450 nm stimulates the phosphor to irradiate a white-color illumination. The other laser, with a wavelength of 410 nm, is used to enhance blood vessels at shallow depth in the mucosa [8] . Early data have shown its usefulness in predicting histology of mucosal lesions [9, 10] . When this study was first conceived, there were no published data on the role of BLI in polyp detection. Since then, further limited data have been published [11, 12] . The NICE and JNET classification systems for polyp diagnosis were developed using NBI. Published data on BLI for detection and differentiation of colonic polyps are limited compared to NBI.
This study aimed to determine whether BLI can increase detection of colonic adenomas when compared to WLI. It also examined use of NICE and JNET classification systems with the BLI system to predict histology. For screening, the BLI bright mode was used and for magnified observation, the BLI mode was used.
Patients and methods

Study design and setting
This was a prospective, randomized study comparing BLI with WLI. It was conducted from July 2017 to March 2019 at the Department of Gastroenterology and Hepatology, Changi General Hospital, which is a regional teaching hospital serving the eastern part of Singapore. All patients provided written informed consent for study participation. The study protocol was approved by the institutional review board (CIRB 2016/3054) and registered with Clinicaltrials.gov (NCT03421600).
Patients
Patients were included if they were aged 50 years or above and referred for colonoscopy for diagnostic evaluation of colonic symptoms, surveillance of colorectal polyps, or colorectal cancer screening. Patients were excluded it they had acute lower gastrointestinal bleeding, familial colorectal cancer syndrome including familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer syndrome, known inflammatory bowel disease, bloody diarrhea, previous colonic resection, previous extensive abdominal or pelvic surgery where colonoscopy may be considered difficult, were considered unsafe for biopsies or polypectomy due to bleeding tendency, or in situations in which complete colonoscopy could not be completed or performed or a patient had severe comorbid illnesses (ASA 3 and above).
Randomization
Patients were randomized in a 1:1 ratio in blocks of 10 to undergo either BLI or WLI colonoscopy. Randomization was carried out by computer-generated random sequences. Individual random sequence was placed in an opaque envelope and kept by an independent research assistant who was not involved in this study. Once informed consent was obtained, and upon reaching the cecum, the envelope was opened and the assigned imaging technique (BLI or WLI) was disclosed to the endoscopist. The gastrointestinal pathologist reporting on the histology was blinded to the polyp endoscopic appearance based on NICE and JNET classifications.
Technique of colonoscopy and imaging
Patients received 4 L of polyethylene glycol in a split dose for bowel cleansing before colonoscopy. An endoscopy system with BLI and WLI functions and optical magnification capability was used (LASEREO, Fujifilm, Tokyo, Japan). Colonoscopy was performed under conscious sedation with intravenous midazolam and/or fentanyl. In the BLI group, insertion to cecum was performed under WLI and once the cecum was reached, the BLI bright mode was switched on during endoscope withdrawal for complete colonic examination. In the WLI group, WLI was used during both insertion and withdrawal. Bowel preparation of the whole colon was graded according to the Boston Bowel Preparation Scale [13] .
Size and location of all colonic polyps were recorded contemporaneously. Size of colonic lesions was measured against the span of an opened biopsy forceps. Regardless of the assigned group, once a polyp was detected during withdrawal, prior to removal, the surface structure of each polyp detected was first assessed without optical magnification under BLI bright mode using NICE classification. Thereafter optical magnification was applied and the polyp was classified using JNET classification using BLI mode. Images were captured electronically. All lesions were resected or biopsied and sent for histological examination. All procedures were performed by experienced endoscopists. Prior to the start of the study, NICE and JNET classifications were formally reviewed with all participating endoscopists to ensure familiarity with these classifications for polyp assessment.
Definitions
Complete colonoscopy was defined as successful cecal intubation. Histological interpretation of all polyps followed the World Health Organization system [14] . Advanced adenoma was defined as adenoma ≥ 10 mm in diameter, villous histology, high-grade dysplasia (HGD), or intramucosal carcinoma [5] . Adenoma and polyp detection rates were defined as the proportion of patients with at least one adenoma and one polyp respectively.
Statistics
The initial sample size estimation was based on the assumption that BLI was superior to WLI for adenoma detection. We estimated the overall prevalence of colorectal adenoma in the WLI colonoscopy group to be 25 %. To show a clinically important improvement of adenoma detection by BLI, we assumed that BLI should increase the adenoma detection rate by 15 %. With a statistical power of 80 % and a two-sided significance level of 0.05, 152 patients would be needed in each study arm, such that the total study population was 304 patients. We conducted an interim blinded analysis at study midpoint to assess the trend and to guide us on further conduct of the study in terms of study continuation or early termination. With group sequential analysis, the Pocock boundary gave a P value threshold for each interim analysis which guided the decision on whether to stop the trial. If a single mid-point interim analysis was performed the nominal significance level corresponding to an overall significance level of 0.05 was 0.0294 [15] .
Colonic polyp and adenoma detection rates of the BLI and WLI groups were compared using chi-square test. Statistical significance was taken as two-sided P < 0.05. Using histology as gold standard, sensitivity, specificity, positive and negative predictive values, and accuracy of NICE and JNET classifications were calculated. Statistical analysis was performed using SPSS software (version 20.0; SPSS, Chicago, IL) and MedCalc statistical software (www.medcalc.org).
Results
Patient characteristics
During the study period from July 2017 to March 2019, 184 patients were screened. Two were excluded as they did not meet inclusion criteria and 182 patients were randomized to either BLI (92) or WLI. (90) colonoscopy (▶ Fig. 1 ). Ten experienced endoscopists performed the study examinations. Mean age of patients was 62.9 years (± 8.5) and 56.6 % were men. There was no significant difference in clinical characteristics between the two groups. There was no significant difference in quality of bowel preparation and withdrawal time between the two groups (▶ Table 1 ). No complications occurred during colonoscopy.
A total of 194 polyps (sessile or flat: 175; pedunculated: 19; mean size 4 mm [range: 1 to 20 mm] were detected in 91 patients. Polyp histology was hyperplastic in 78, inflammatory pseudo-polyp in one, sessile serrated polyp or adenoma in 22, adenoma with low-grade dysplasia (LGD) in 88, and high-grade dysplasia (HGD) in four. One resected polyp could not be retrieved. One patient had advanced rectal adenocarcinoma.
Adenoma detection rate and endoscopichistological correlation
Comparing BLI with WLI, the adenoma detection rate was 46. Fig. 2, ▶ Fig. 3, ▶ Fig. 4, ▶ Fig. 5 , ▶ Fig. 6, ▶ Fig. 7, ▶ Fig. 8 and ▶ Table 2 ).
Discussion
It is crucial to maximize adenoma detection rates (ADRs) to improve long term outcomes in patients with colorectal neoplasia. The use of image enhanced endoscopy (IEE), the focus of the current study, is just one aspect of the overall strategy. The cornerstone for achieving this is good-quality endoscopy ▶ performed by individual endoscopists, with surrogate markers being good bowel preparation, slow withdrawal time, and the individual endoscopist's personal ADR [16] . Other strategies that have been investigated to further enhance ADR include use of IEE as in this study, use of add-on devices, use of fullspectrum endoscopy system (FUSE) as well artificial intelligence [17, 18] . Our study focused on BLI, a type of IEE that utilizes a narrow bandwidth light source to accentuate mucosal surface contrast. Our study demonstrated that BLI could increase ADR compared to WLI. In addition, it validated use of NICE and JNET classification in the context of BLI for patients with hyperplastic polyps and adenomatous polyps with LGD. Previous publications applied NICE and JNET classifications only in the context of using NBI. It is not surprising that studies using the old generation NBI systems did not demonstrate any benefit in the context of polyp detection, because dark illumination hampers far-view visualization [4] . To date only one other study has demonstrated that IEE using NBI can increase polyp and ADR [5] . Leung et al reported that when the new-generation NBI system was compared with WLI, it significantly increased polyp and ADR. The newer-generation endoscopy systems with NBI, be it NBI in the study by Leung, or BLI in our study, combine the ability to accentuate mucosa surface details, which is crucial for detailed examination of a lesion, with the benefit of a brighter light source, thus improving visualization of distant lesions.
Even then, having good bowel preparation is especially crucial during colonoscopy with IEE techniques, as suboptimal bowel preparation would interfere with endoscopic visualization more than WLI, due to the darker appearance.
In the study by Leung, both ADR and polyp detection rates were significantly higher in the NBI group compared with the WLI group (adenoma: 48.3 % vs. 34.4 %, P = 0.01; polyps: 61.1 % vs. 48.3 %, P = 0.02). The mean number of polyps detected per patient was also higher in the NBI group (1.49 vs. 1.13, P = 0.07) [5] . Three other prospective randomized controlled trials utilizing brighter narrow bandwidth technology (1 NBI and 2 BLI) have been published so far [11, 12, 19] . In the other study using NBI, Horimatsu used the Olympus next-generation NBI system with either standard-definition (SD) or wide-angle (WA) colonoscopy and stratified patients into four groups: SD WLI v SD NBI, and WA WLI vs WA NBI. The primary endpoint of the study was mean number of polyps detected per patient. The mean number of polyps detected per patient was significantly higher in the NBI group than in the WLI group (2.01 vs. 1.56; P = 0.032) [19] . Ikematsu randomized patients to WLI or BLI with mean number of adenomas per patient as the primary outcome. This was significantly higher in the BLI group (1.27 vs. 1.101, P = 0.008). There was no difference in ADR between the BLI and WLI groups (54.8 % vs. 52;7 %, P = 0.521) [11] . Shimoda randomized patients to tandem colonoscopy with BLI followed by WLI (BLI-WLI group) or WLI followed by WLI (WLI-WLI group). The main outcome measure was the adenoma miss rate. The miss rate in the BLI-WLI group was (1.6 %), which was significantly less than that in the WLI-WLI group (10.0 %, P = 0.001) [12] . Our study differed from the other BLI studies by focusing on ADR, rather than mean number of adenomas per patient [11] or adenoma miss rates [12] .
The NICE and JNET classification systems were developed using NBI. There had been no prior validation of these systems with histopathological correlation using BLI. Our study formally examined application of NICE and JNET using BLI, which has not been previously published. Our study showed that similar to NBI, these classification systems could be applied using BLI to predict polyp histology. Nonetheless, there are discrepancies between endoscopic and histological diagnoses, thus histological correlation is still important. The classification systems could not reliably diagnose sessile serrated polyps or adenomas. Images of the four cases with HGD were reviewed and confirmed to be truly JNET 2A in appearance and not JNET 2B. On histology, the HGD component of these cases was focal (less than 10 % of the entire adenoma), located towards the basal aspect without extension to the surface of the mucosa and often lacked the well-established microvasculature of an advanced adenoma. Hence, these early HGD foci are not visible endoscopically.
In terms of study strength, this was an investigator-initiated, randomized controlled study performed by experienced endoscopists who regularly used NBI in routine clinical practice. Thus it was not difficult to apply BLI. There was formal pretrial training to ensure that all endoscopists were familiar with the endoscopy system and use of the NICE and JNET classification systems. We acknowledge our study limitations. This was a single-center study with relatively small sample size. However, this was because we terminated our study earlier as the actual effect size was larger than initially calculated. In addition, there were no adenomas with JNET2B morhology in our cohort of patients. Withdrawal time does impact on detection rate, and in our study, we looked at withdrawal time from the perspective of a threshold minimum of 6 minutes, rather than the difference between groups of actual mean withdrawal time.
Conclusion
To conclude, BLI increased colonic ADR. NICE and JNET classifications could be used to predict hyperplastic or adenomatous polyps.
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